Torbjörn Bjerke
CEO
CEO since 2011.
Born 1962.
MD.
Torbjörn Bjerke has over 20 years of experience in the pharmaceutical industry including roles as President and CEO of Orexo AB a position he held from 2007 until January 2011,
President and CEO of Biolipox AB and Director of Pharmacology at AstraZeneca. He has also served as Executive Vice President of R&D at ALK-Abello.
Other appointments
Chairman of Pergamum AB, Board member of NeuroSearch AS, Axelar AB, Aprea AB, Pharmanest AB and the Paris based DBV Technologies.
Holdings in Karolinska Development: 11 375 shares.
+46 (0) 72 744 41 23
